1. Home
  2. QTTB vs MIND Comparison

QTTB vs MIND Comparison

Compare QTTB & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$5.85

Market Cap

97.5M

Sector

Health Care

ML Signal

HOLD

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$7.05

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
MIND
Founded
2015
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
97.5M
83.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
QTTB
MIND
Price
$5.85
$7.05
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
227.6K
122.5K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
136.78
N/A
EPS
N/A
N/A
Revenue
$53,737,000.00
N/A
Revenue This Year
N/A
$23.31
Revenue Next Year
N/A
$1.01
P/E Ratio
N/A
$22.27
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$5.51
52 Week High
$8.05
$14.50

Technical Indicators

Market Signals
Indicator
QTTB
MIND
Relative Strength Index (RSI) 51.75 51.35
Support Level $5.51 $6.50
Resistance Level $6.37 $9.22
Average True Range (ATR) 0.54 0.35
MACD 0.03 0.09
Stochastic Oscillator 56.79 64.72

Price Performance

Historical Comparison
QTTB
MIND

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

Share on Social Networks: